BTAI Bioxcel Therapeutics Inc.

BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company which is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology.

$45.36  +2.40 (5.59%)
As of 03/05/2021 15:59:45 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Small cap
Health Care
Biotechnology
USA
USA
03/08/2018
24,368,357
518,873
$1,101,449,736
0.00%
SEC Edgar Online
10-Q
10-K
09075P105
US09075P1057
BF4VBS8

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-44.50
23.68
0.00
-31.39%
-346,790.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy